Sen, A., Akinola, M., Tai, X. Y., Symmonds, M., Davis Jones, G., Mura, S., . . . Husain, M. (2021). An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): A double-blind, placebo-controlled, randomised crossover proof of concept study. Trials.
Chicago Style citaatSen, Arjune, et al. "An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): A Double-blind, Placebo-controlled, Randomised Crossover Proof of Concept Study." Trials 2021.
MLA citatieSen, Arjune, et al. "An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): A Double-blind, Placebo-controlled, Randomised Crossover Proof of Concept Study." Trials 2021.
Let op: Deze citaties zijn niet altijd 100% accuraat.